Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Prostatic Neoplasms 2Lung Neoplasms 2Thymus Neoplasms 1Small Cell Lung Carcinoma 1Retinoblastoma 1Pancreatic Neoplasms 1Neoplasms 1Meningioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Gliosarcoma 1Glioblastoma 1Eye Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoid Tumor 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 8Radiotherapy 7Fluorouracil 6Neoadjuvant Therapy 4Irinotecan 4pembrolizumab 3Paclitaxel 3Gefitinib 3Carboplatin 3toripalimab 2spartalizumab 2Oxaliplatin 2Nivolumab 2Esophagectomy 2Docetaxel 2vandetanib 1tislelizumab 1sitravatinib 1ribociclib 1oblimersen 1nazartinib 1liposomal doxorubicin 1apatinib 1Surgical Procedures, Operative 1SGN-LIV1A 1Proton Therapy 1Pemetrexed 1Panitumumab 1Nutritional Support 1Leucovorin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Esophageal Squamous Cell Carcinoma × Proton Therapy × Clear all
NCT02023541 2015-04-07

Proton Beam Therapy to Treat Esophageal Cancer

Washington University School of Medicine

Phase 1 Terminated
3 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡